Pedro Bilbao Zulaica-rekin lankidetzan egindako argitalpenak (24)

2019

  1. Are there enough radiation oncologists to lead the new Spanish radiotherapy?

    Clinical and Translational Oncology, Vol. 21, Núm. 12, pp. 1663-1672

  2. Late toxicity after single dose HDR prostate brachytherapy and EBRT for localized prostate cancer: Clinical and dosimetric predictors in a prospective cohort study

    Radiotherapy and Oncology, Vol. 135, pp. 13-18

  3. Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT

    European Journal of Cancer Care, Vol. 28, Núm. 5

2018

  1. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

    Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584

  2. Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial

    Radiotherapy and Oncology, Vol. 126, Núm. 2, pp. 278-282

  3. Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 402-410

  4. Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 5, pp. 1172-1178

2017

  1. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma

    Clinical and Translational Oncology, Vol. 19, Núm. 11, pp. 1337-1349

  2. Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision

    Brachytherapy, Vol. 16, Núm. 1, pp. 201-206

2016

  1. Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial

    Radiotherapy and Oncology, Vol. 119, Núm. 1, pp. 91-96

  2. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist

    British Journal of Radiology, Vol. 89, Núm. 1067

  3. Salvage high-dose-rate brachytherapy for histologically confirmed macroscopic local relapsed prostate cancer after radical prostatectomy

    Journal of Contemporary Brachytherapy, Vol. 8, Núm. 6, pp. 477-483

2015

  1. Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: Multicenter prospective observational study

    BMC Palliative Care, Vol. 14, Núm. 1

  2. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 9, pp. 1378-1389

2014

  1. A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy

    Chinese Journal of Cancer, Vol. 33, Núm. 4, pp. 204-210

  2. A prospective analysis of inter- and intrafractional errors to calculate CTV to PTV margins in head and neck patients

    Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 113-120

  3. Evaluación de radioterapia conformada con haces de intensidad modulada: IMRT

    Servicio Central de Publicaciones = Argitalpen Zerbitzu Nagusia

  4. Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy

    Journal of Contemporary Brachytherapy, Vol. 6, Núm. 2, pp. 154-160

  5. Stereotactic body radiotherapy: An attractive treatment modality for recurrent head and neck carcinoma. (Regarding Lartigau et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer)

    Radiotherapy and Oncology

  6. The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach

    Cancer Treatment Reviews, Vol. 40, Núm. 1, pp. 178-189